A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 7.20% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -55.16%. Over the past 30 days, the price of OLMA has fallen by 13.64%. And in the last five days, it has fallen by -1.26%.
Olema Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $16.77 on 02/13/24, while the lowest value for the same period was recorded at $4.60 on 01/13/25.
52-week price history of OLMA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Olema Pharmaceuticals Inc’s current trading price is -62.74% away from its 52-week high, while its distance from the 52-week low is 35.87%. The stock’s price range during this period has varied between$4.60 and $16.77. The Olema Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.52 million for the day, a figure considerably lower than their average daily volume of 1.09 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Olema Pharmaceuticals Inc (OLMA) has experienced a quarterly decline of -47.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 427.08M and boasts a workforce of 74 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.29, with a change in price of -5.60. Similarly, Olema Pharmaceuticals Inc recorded 835,172 in trading volume during the last 100 days, posting a change of -47.26%.
OLMA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for OLMA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
OLMA Stock Stochastic Average
Olema Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 26.07%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 78.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 84.39% and 79.60%, respectively.
